 Head of Therapeutic Business Unit,Lead PL/CL team cross the Great China, APAC and global delivery.  Work as Great China management team (CLT) member, contribute to the Great China strategy, goals, process optimization and resource allocation. Collaborate with BD for Great China leading business with China region, APAC and global participation. Support global BD for global programs business. Be accountable for key metrics, financial goals of Great China leading but with APAC or global scale projects Oversight and manage APAC and Great China EBP client

 Work as regional head of APAC in ICO, leading the APAC late phase business, development strategy/ portfolio.  Work as ICO global senior management team (SMT) member, contribute to the business/strategy/organization of Asia and global. Lead APAC ICO team and oversighting the deliveries in the region. Provides senior oversight to review/approval of business proposal, execution plan and project financials etc. in APAC region Leads the management of strategic alliances with internal and external customers.  Leads in organization and participation in various external communication opportunities – speaking at conferences, contribute to journal articles, etc.  Set up efficient collaboration mechanism with US/ EU team and

 Lead APAC CTM and PM team to manage the project deliveries, including timelines, processes, SOPs, quality and financial performance. 10+ direct reports in China, SKR, JP， AU, India and Philippine covered 20+ ongoing projects in APAC. JOC member with the key clients in regional level.

 Focus on the international multi center project management, work as the new product team leader. Lead the project cross functional team (physicians, safety lead, study operation leaders, stat. DM, partner representatives and vendor representatives etc.) Major area includes GI/ Onco/ Auto-Immune / Respiratory.  Familiar with the medical system, regulatory environment, operation process/standard of USA/Canada/Australia/New Zealand/Japan etc. Experienced at site control in USA/Canada/Australia/New Zealand/Japan / other Asia area  Work with global product team and Partner core team to get the strategy and budget approval and facilitate the negotiation and communication with senior management team from both companies.  Experienced at collaborate with the 3rd party CRO and partners: Quintiles, Covance, ICON, Ironwood, Pearl Co., Ardea Bio etc.  Lead the Due Diligence process of R&D part Familiar with the business case/development plan setting up.Cooperate with the commercial/Reg/Operation/Medical/Legal/Finance, lead the business case and development plan. The program includes Auto-Immune/lesinurad gout and Anifrolumab SLE and LN; linaclotide IBS constipation; 3 triple treatment of COPD; AZD 3043 general anesthesia; Onco/ Caprelsa thyroid cancer; etc.

Contributed to set up China portfolio & project management process. •Worked with global team for the new drug introduction.•Combined marketing, medical, manufacture and regulatory needs for the molecule/new indication/line extension into an integrated development plan. •Led team from different function (marketing, medical, regulatory, finance, etc.) to implement drug development strategy and drive submission, approval and launch. •Led the timeline, budget set up, resource request etc. •Managed cross-functional communication, anticipate and resolve issues with the team.•Provided guide and support to Operation team.

Successfully managed multiple new drugs/new indications clinical trials and hospital cooperators. •Responsible to control the new drug development budget, quality, milestone completion, etc. and 3rd party cooperators management.

Focused on phase IV and post marketing study management as well as hospital cooperator management. Balanced the scientific request and business needs. •Provided medical supports to differentiate the drug with key competitors.

Conducted Pharmaceutical Kinetics studies for new drugs

Conducted pharmacy research and drug manufacturing.